Ultragenyx Pharmaceutical
RARE
RARE
236 hedge funds and large institutions have $3.87B invested in Ultragenyx Pharmaceutical in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 94 increasing their positions, 75 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.1% less ownership
Funds ownership: 98.74% → 98.64% (-0.1%)
1% less call options, than puts
Call options by funds: $23.1M | Put options by funds: $23.4M
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Holders
236
Holding in Top 10
3
Calls
$23.1M
Puts
$23.4M
Top Buyers
| 1 | +$59.7M | |
| 2 | +$57.5M | |
| 3 | +$56.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$55.8M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$36.2M |
Top Sellers
| 1 | -$44.6M | |
| 2 | -$30.3M | |
| 3 | -$23.8M | |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$14.7M |
| 5 |
Hudson Bay Capital Management
Stamford,
Connecticut
|
-$9.47M |